» Articles » PMID: 32206469

Multiple Sclerosis Patients in Saudi Arabia: Prevalence of Depression and Its Extent of Severity

Overview
Journal Cureus
Date 2020 Mar 25
PMID 32206469
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Background Multiple sclerosis (MS) is a serious chronic autoimmune disorder of the central nervous system of unknown etiology. MS-related depression is a common mood disorder recognized within the medical community. However, their association is ambiguous, underdiagnosed, undertreated and less reported. Objectives The study aimed to estimate the point prevalence and severity of depression among multiple sclerosis patients in Saudi Arabia. Materials and methods We conducted an observational cross-sectional study among multiple sclerosis patients in Riyadh region, Saudi Arabia. Patients filled demographic data and Patient Health Questionnaire-9 (PHQ-9) to determine depression. Those who did not meet the age, disease duration, and regular follow-up eligibility criteria were excluded from the study. Results We enrolled 238 MS patients in the study, male patients represented 39.1% (n = 93) while females accounted for 60.9% (n = 145) (male:female ratio 0.64). The mean age of the study population was 32.07 ± 7.93 years. The mean duration of the disease was 7.06 ± 4.7 years. We determined that 89.9% (n = 214) of the patients showed mild to severe depression symptoms (55.46% of the females, and 34.4% of the males; p = 0.474). We further found that 37.39% (n = 89) and 65.13% (n = 155) of the depressed patients were unemployed (p = 0.039) and were non-smokers (p = 0.097) respectively. Furthermore, depression severity is significantly associated with education (p = 0.005). Conclusion High levels of depression symptoms were found among MS patients in Saudi Arabia. The relationship between MS and psychiatric conditions exists despite the uncertainty of its pathogenesis. Further longitudinal studies should be carried out to obtain more valid outcomes. Neurologists treating MS patients can play a role in studies related to the condition by investigating depressive symptoms actively and providing the data.

Citing Articles

Depression and anxiety in multiple sclerosis. Review of a fatal combination.

Jellinger K J Neural Transm (Vienna). 2024; 131(8):847-869.

PMID: 38869643 DOI: 10.1007/s00702-024-02792-0.


The prevalence of major depression and generalized anxiety disorder in patients with multiple sclerosis in Saudi Arabia: a cross-sectional multicentered study.

Alswat A, Altirkistani B, Alserihi A, Baeshen O, Alrushid E, Alkhudair J Front Psychiatry. 2023; 14:1195101.

PMID: 37706033 PMC: 10496114. DOI: 10.3389/fpsyt.2023.1195101.


The Psychological Impact of COVID-19 Pandemic on Persons with Multiple Sclerosis in Saudi Arabia.

Alshammari A, Alshammari K, Alshammari S, Aldhaifi S, Alqahtani A Neurosciences (Riyadh). 2023; 28(2):108-115.

PMID: 37045454 PMC: 10155471. DOI: 10.17712/nsj.2023.2.20110104.


Impact of Multiple Sclerosis and Its Association with Depression: An Analytical Case-Control Investigation.

Ruiz-Sanchez F, Martins M, Soares S, Romero-Morales C, Lopez-Lopez D, Gomez-Salgado J Healthcare (Basel). 2022; 10(11).

PMID: 36360559 PMC: 9690715. DOI: 10.3390/healthcare10112218.


Unmet Needs and Treatment of Relapsing-Remitting Multiple Sclerosis in Saudi Arabia: Focus on the Role of Ofatumumab.

Craner M, Al Malik Y, Babtain F, Alshamrani F, Alkhawajah M, Alfugham N Neurol Ther. 2022; 11(4):1457-1473.

PMID: 36048334 PMC: 9434517. DOI: 10.1007/s40120-022-00401-4.


References
1.
Minden S, Orav J, Reich P . Depression in multiple sclerosis. Gen Hosp Psychiatry. 1987; 9(6):426-34. DOI: 10.1016/0163-8343(87)90052-1. View

2.
Eaton W, Anthony J, Gallo J, Cai G, Tien A, Romanoski A . Natural history of Diagnostic Interview Schedule/DSM-IV major depression. The Baltimore Epidemiologic Catchment Area follow-up. Arch Gen Psychiatry. 1997; 54(11):993-9. DOI: 10.1001/archpsyc.1997.01830230023003. View

3.
Beiske A, Svensson E, Sandanger I, Czujko B, Pedersen E, Aarseth J . Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol. 2008; 15(3):239-45. DOI: 10.1111/j.1468-1331.2007.02041.x. View

4.
Weissman M, Bland R, Canino G, Faravelli C, Greenwald S, Hwu H . Cross-national epidemiology of major depression and bipolar disorder. JAMA. 1996; 276(4):293-9. View

5.
Taylor K, Hadgkiss E, Jelinek G, Weiland T, Pereira N, Marck C . Lifestyle factors, demographics and medications associated with depression risk in an international sample of people with multiple sclerosis. BMC Psychiatry. 2014; 14:327. PMC: 4263016. DOI: 10.1186/s12888-014-0327-3. View